Paid Trial Alerts

Syneos Health Early Phase Clinical Research Unit — Miami in Miami, FL

What we have seen on this clinic's public recruitment page. Telegram still carries new studies first; this page is the record between posts. Missing pay or dates are omitted — we do not guess them.

Open right now

Last 90 days

  1. — Listed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072980-cohort-4a/
  2. — Closed: 7077479
  3. — Closed: Overweight Participants
  4. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  5. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  6. — Closed: 7077479
  7. — Closed: Overweight Participants
  8. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  9. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  10. — Listed: 7077479
  11. — Listed: Overweight Participants
  12. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  13. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  14. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  15. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  16. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  17. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  18. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  19. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  20. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  21. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  22. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  23. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  24. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  25. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  26. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  27. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  28. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  29. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  30. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  31. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  32. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  33. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  34. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  35. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  36. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  37. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  38. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  39. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  40. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  41. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  42. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  43. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  44. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  45. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  46. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  47. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  48. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  49. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  50. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  51. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  52. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  53. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  54. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  55. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  56. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  57. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  58. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  59. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  60. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  61. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  62. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  63. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  64. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  65. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  66. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  67. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  68. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  69. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  70. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  71. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  72. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  73. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  74. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  75. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  76. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  77. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  78. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  79. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  80. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  81. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  82. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  83. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  84. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  85. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  86. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  87. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  88. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  89. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  90. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  91. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  92. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  93. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  94. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  95. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  96. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  97. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  98. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  99. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  100. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  101. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  102. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  103. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  104. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  105. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  106. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  107. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  108. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  109. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  110. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  111. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  112. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  113. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  114. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  115. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  116. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  117. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  118. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  119. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  120. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  121. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  122. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  123. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  124. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  125. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  126. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  127. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  128. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  129. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  130. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  131. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  132. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  133. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  134. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  135. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  136. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  137. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  138. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  139. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  140. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  141. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  142. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  143. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  144. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  145. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  146. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  147. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  148. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  149. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  150. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  151. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  152. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  153. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  154. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  155. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  156. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  157. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  158. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  159. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  160. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  161. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  162. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  163. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  164. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  165. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  166. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  167. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  168. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  169. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  170. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  171. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  172. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  173. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  174. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  175. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  176. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  177. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  178. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  179. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  180. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  181. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  182. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  183. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  184. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  185. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  186. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  187. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  188. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  189. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  190. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  191. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  192. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  193. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  194. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  195. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  196. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  197. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  198. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  199. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  200. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  201. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  202. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  203. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  204. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  205. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  206. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  207. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  208. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  209. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  210. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  211. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  212. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  213. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  214. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  215. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  216. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  217. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  218. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  219. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  220. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  221. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  222. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  223. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  224. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  225. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  226. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  227. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  228. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  229. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  230. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  231. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  232. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  233. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  234. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  235. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  236. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  237. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  238. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  239. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  240. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  241. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  242. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  243. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  244. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  245. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  246. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  247. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  248. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  249. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  250. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  251. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  252. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  253. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  254. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  255. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  256. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  257. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  258. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  259. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  260. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  261. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  262. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  263. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  264. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  265. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  266. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  267. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  268. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  269. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  270. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  271. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  272. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  273. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  274. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  275. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  276. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  277. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  278. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  279. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  280. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  281. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  282. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  283. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  284. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  285. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  286. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  287. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  288. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  289. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  290. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  291. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  292. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  293. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  294. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  295. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  296. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  297. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  298. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  299. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  300. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  301. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  302. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  303. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  304. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  305. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  306. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  307. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  308. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  309. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  310. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  311. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  312. — Closed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/
  313. — Listed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7072457-sad-1/
  314. — Listed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/7077479/
  315. — Listed: https://www.us-participants.syneoshealth.com/en/avalaible-studies/overweight-participants/

Clinic listing page